SCHEMBL5309132

SCHEMBL5309132

Cc1ccc(/C=N/c2ccc(S(N)(=O)=O)cc2)cc1C

nearest known ligand 0.71

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 10/20 0.71
▸ CA9 Q16790 8/20 0.71
▸ CA1 P00915 8/20 0.71
▸ CA7 P43166 2/20 0.71
▸ PTGS2 P35354 16/20 0.70
▸ PTGS1 P23219 9/20 0.70
▸ CA12 O43570 6/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5309135 1.00 CA2 (0.71) CA2CA9CA1CA7PTGS2
SCHEMBL5312579 0.91 CA2 (0.71) CA2CA9CA1CA7PTGS2
SCHEMBL5312581 0.91 CA2 (0.71) CA2CA9CA1CA7PTGS2
SCHEMBL5309207 0.85 PTGS2 (0.81) CA2CA9CA1CA7PTGS2
SCHEMBL5309203 0.85 PTGS2 (0.81) CA2CA9CA1CA7PTGS2
SCHEMBL5312743 0.83 PTGS2 (1.00) CA2CA9CA1CA7PTGS2
SCHEMBL5309673 0.83 PTGS2 (1.00) CA2CA9CA1CA7PTGS2
SCHEMBL5312741 0.83 PTGS2 (1.00) CA2CA9CA1CA7PTGS2
SCHEMBL5309671 0.83 PTGS2 (1.00) CA2CA9CA1CA7PTGS2
SCHEMBL5309663 0.81 PTGS2 (0.74) CA2CA9CA1CA7PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799823-B1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses DAIICHI SANKYO CO LTD (JP) 2007-10-31 — — EP disclosed
US-RE39420-E1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses SANKYO COMPANY, LIMITED (JP) 2006-12-05 — — US disclosed
US-5908858-A OSTEOPOROSIS; LEUKOTRIENE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1999-06-01 — — US disclosed
EP-0799823-A1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1997-10-08 — — EP disclosed
Send feedback